ABSTRACT
Clothes form indispensible trade in modern society & jeans clothes are among the clothes with highest demand among youth. Most of the times the jeans fabrics are made in some industries and then they are transported to different small scale industries to make readymade clothes. Mostly these small scale industries consist of small labour force mostly involved in cutting & making of readymade jeans clothes. Most of these industries are unorganised sectors. This study intends to assess morbidity patterns workers in one of such industries invoved in cutting & making of readymade jeans clothes. Objective: To assess the morbidity pattern among the workers. Material & Methods: It is a crossectional study conducted in one of the small factory producing readymade jeans clothes. The total number of workers included was 256. The objective of the study was to assess the morbidity among the workers. The study tool used was a pre validated &pretested questionnaire, which included their demographic characteristics, general & systemic examination. Results: Among all the 256 workers in the factories, highest number i.e. 136 (53.13%) were in 20-30 year age group followed by 68(26.56%) in 30-40 year age group, 24(9.38%) each in 10-20 years & 40-50 years age group and only 4(1.56%) were in 50-60 years of age group. All of them were males. Conclusion: The health needs of the people working in these industries are high due to significant co morbidities, long working hours, lack of health awareness regarding substance abuse and safe sexual practice.
ABSTRACT
OBJECTIVES: 1. To compare the protective antibody titres on day 14, 30 and 90 after giving intramuscular (IM) injections of PCECV and subcutaneous injections of Nervous Tissue Vaccine. 2. To compare the immunogenicity and safety of PCECV and NTV. METHODS AND MATERIALS: The study enrolled cases in three groups.Group 'C' or control group: (n = 38) : This group comprised of 38 normal healthy volunteers without dog-bite. Group 'A' (n = 102): This group included cases of dog-bite fulfilling inclusion/exclusion criteria. Each one of Group A and C were given PCECV as post exposure treatment (PET) on day 0-3-7-14-30 and 90. Group 'B' (n = 50): This group included 50 cases of dog-bite who received NTV. The rabies virus neutralizing antibody titres were estimated by RFFIT (Rapid Fluorescent Focus Inhibition Test) on day 0, 14, 30 and 90 days. 45 recipients of PCECV were re-tested for persistence of Protective Antibodies at the end of 1 year. RESULTS: Of these 37, 91 and 45 cases were evaluable in Groups C, A and B respectively. The antibody titres in Groups A, B, C were 13.4, 3.2, 22.8 IU/ml respectively; the protective titre being 0.5 IU/ml.5% PCECV recepients had delayed response on day 30.14% of NTV recepients did not seroconvert. CONCLUSIONS: The Immunogenicity, Reactogenicity and safety of PCECV is well established. 5% of PCECV receipients showed a delayed sero conversion. 14% of NTV receipients did not sero convert at all.Therefore it is desirable to estimate antibody titres on day 14 after vaccination. If difficult, then all the cases of animal bite must receive passive immunization with rabies immunoglobulins.